Skip to Main Content
<< Back | Return to Main COMAR Search Page

10 records match your request.

FileAbstract
10.06.07.00.htm 10.06.07.00. Title 10 MARYLAND DEPARTMENT OF HEALTH Subtitle 06 DISEASES Chapter 07 Sexually Transmitted Infections ― Expedited Partner Therapy for Chlamydia and Gonorrhea Authority: Health-General Article, §2-104(b) 18-102, 18-201, 18-202, and 18-214.1, Annotated Code of Maryland
10.06.07.01.htm 10.06.07.01. 01 Purpose and Scope.. A. The purpose of expedited partner therapy in Maryland is to:. 1) Provide antibiotic therapy to any partner of a patient diagnosed with chlamydia or gonorrhea without a personal physical assessment of the partner, and without having a previous provider-patient relationship with the partner;2) Contain and stop the further spread of chlamydia and gonorrhea; and. 3) Reduce the likelihood of reinfection in the diagnosed patient.. B. This chapter applies t
10.06.07.02.htm 10.06.07.02. 02 Definitions.. A. In this chapter, the following terms have the meanings indicated.. B. Terms Defined.. 1) “Antibiotic therapy” means the oral antibiotic drug regimens currently recommended by the Centers for Disease Control and Prevention for the treatment of chlamydia and gonorrhea through expedited partner therapy.2) “Department” means the Maryland Department of Health.. 3) “Expedited partner therapy (EPT) means the prescribing or dispensing of antibiotic therapy to any
10.06.07.03.htm 10.06.07.03. 03 Partners Eligible for EPT.. Partners eligible for EPT are:. A. Any partner within 60 calendar days of the patient’s diagnosis; or. B. The most recent partner of a patient if the patient has not had sex in the 60 days before diagnosis.
10.06.07.04.htm 10.06.07.04. 04 Health Care Providers Authorized to Prescribe and Dispense EPT.. Notwithstanding any other provision of law, and only in accordance with their current scope of practice, EPT may be prescribed or dispensed by the following health care providers:A. A physician licensed under Health Occupations Article, Title 14, Annotated Code of Maryland;. B. An authorized physician assistant licensed under Health Occupations Article, Title 15, Annotated Code of Maryland, acting
10.06.07.05.htm 10.06.07.05. 05 Prescribing and Dispensing EPT Medications.. A. Antibiotic therapy prescribed or dispensed for EPT shall be in accordance with recommendations from the Centers for Disease Control and Prevention.B. Prescribing.. 1) A separate prescription shall be issued for each partner;. 2) The designation “EPT” or “Expedited Partner Therapy” shall be included on the face of the prescription for each prescription issued;
10.06.07.06.htm 10.06.07.06. 06 Counseling and Educational Information Requirements.. A. A health care provider prescribing or dispensing EPT to a patient shall:. 1) Counsel the patient to encourage each partner to seek a personal physical assessment; and. 2) Provide the patient with educational information for each partner, in accordance with §C of this regulation.B. A pharmacist dispensing EPT shall provide educational information for each partner, in accordance with §C of this regulation.
10.06.07.07.htm 10.06.07.07. 07 Documenting EPT in a Medical Chart.. A. A health care provider prescribing or dispensing EPT shall document the provision of EPT in the patient’s chart.B. Documentation shall include the:. 1) Number of EPT prescriptions or medications provided to the patient for each partner; and. 2) Medication and dosage being provided to the patient for each partner..
10.06.07.08.htm 10.06.07.08. 08 Reporting of Chlamydia and Gonorrhea by a Health Care Provider or Institution.. A. This chapter may not affect the obligation of a health care provider or institution to report to a health officer cases of chlamydia and gonorrhea and the treatment provided to those cases in accordance with COMAR 10.06.01.04.B. When reporting a case of chlamydia or gonorrhea for which EPT was prescribed or dispensed, a health care provider or institution shall report the number of partners for who
10.06.07.9999.htm 10.06.07.9999. Administrative History Effective date: March 28, 2016 (43:6 Md. R. 406).
<< Back | Return to Main COMAR Search Page